Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Vtv Therapeutics Llc patents


Recent patent applications related to Vtv Therapeutics Llc. Vtv Therapeutics Llc is listed as an Agent/Assignee. Note: Vtv Therapeutics Llc may have other listings under different names/spellings. We're not affiliated with Vtv Therapeutics Llc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "V" | Vtv Therapeutics Llc-related inventors


Phenoxy acetic acids and phenyl propionic acids as ppar delta agonists

Phenoxy acetic acids and phenyl propionic acids and their use in improving mitochondrial energy output in a subject are provided herein. The present compounds are activators of pparδ and may be useful for treating conditions mediated by the same.. ... Vtv Therapeutics Llc

Tricyclic compounds as modulators of tnf-alpha synthesis and as pde4 inhibitors

The present invention relates to chemical compounds of formula (i) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by tnf-α or by pde4, including but not limited to ulcerative colitis and crohn's disease.. . ... Vtv Therapeutics Llc

Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

The present invention provides uses of a glucokinase activator in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, improving insulin sensitivity, enhancing phosphorylation of glucose, and improving the therapeutic effectiveness of metformin. ... Vtv Therapeutics Llc

Treatment of mild and moderate alzheimer's disease

The present invention relates to methods of treatment using [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl}-phenoxy)-propyl]-diethyl amine (“compound i”) or a pharmaceutically acceptable salt thereof. In various embodiments, the methods of treatment include treatment of mild-to-moderate dementia of alzheimer's type, diabetes, insomnia, and other indications. ... Vtv Therapeutics Llc

Tricyclic compounds as modulators of tnf-alpha synthesis and as pde4 inhibitors

The present invention relates to chemical compounds of formula (i) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by tnf-α or by pde4, including but not limited to psoriatic arthritis.. . ... Vtv Therapeutics Llc

Bach1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof

The disclosure provides pharmaceutical compositions comprising bach1 inhibitors and nrf2 activators. The disclosure also provides methods of treating diseases such as psoriasis, multiple sclerosis, and copd comprising administering a bach1 inhibitor and a nrf2 activator to a subject in need thereof.. ... Vtv Therapeutics Llc

Phenoxy acetic acids and phenyl propionic acids as ppar delta agonists

Phenoxy acetic acids and phenyl propionic acids and their use in treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance, or obesity are provided herein. The present compounds are activators of pparδ and may be useful for treating conditions mediated by the same.. ... Vtv Therapeutics Llc

Compounds that modulate oxidative stress

. . The present invention provides methods of identifying compounds that selectively induce an oxidative stress response in a biological sample. The present invention further provides methods of treating a subject having a disease associated with oxidative stress using compounds that selectively induce an oxidative stress response in the subject. ... Vtv Therapeutics Llc

Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limb

The present invention provides methods for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limb by administering (e)-[4-[3-(4-fluorophenyl)-3-[4-[3-(morpholin-4-yl)propynyl]phenyl]allyloxy]-2-methyl-phenoxy]acetic acid or a pharmaceutically acceptable salt thereof.. . ... Vtv Therapeutics Llc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Vtv Therapeutics Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Vtv Therapeutics Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###